Companies / Cencora Inc / Activity
Activity — Cencora Inc
40 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | Campbell Elizabeth S Executive | Other | Common Stock | $2.05M | -6K -15.98% | 30,706 0.02% of shares | low |
| Mar 11, 2026 | Cleary James F Executive | Other | Common Stock | $1.89M | -5K -3.26% | 160,357 0.08% of shares | low |
| Jan 20, 2026 | Mauch Robert P. CEO | Sell | Common Stock | $1.81M | -5K -7.10% | 66,726 0.03% of shares | medium |
| Feb 20, 2026 | Mauch Robert P. CEO | Sell | Common Stock | $1.35M | -4K -5.44% | 65,393 0.03% of shares | medium |
| Mar 11, 2026 | Battaglia Silvana Executive | Other | Common Stock | $1.29M | -4K -13.48% | 23,566 0.01% of shares | low |
| Jun 18, 2026 | Durcan Dermot Mark Director | Buy | Common Stock | $1.10M | +4K +14.41% | 31,767 0.02% of shares | high |
| May 28, 2026 | Durcan Dermot Mark Director | Buy | Common Stock | $1.07M | +4K +16.83% | 27,767 0.01% of shares | high |
| Feb 18, 2026 | Mauch Robert P. CEO | Sell | Common Stock | $479.2K | -1K -2.00% | 65,393 0.03% of shares | medium |
| Mar 5, 2026 | Durcan Dermot Mark Director | Grant | Common Stock | $325.1K | +905 +3.96% | 23,767 0.01% of shares | low |
| Jan 20, 2026 | Mauch Robert P. CEO | Exercise | Common Stock | $324.0K | +4K +5.53% | 71,822 0.04% of shares | low |
| Feb 20, 2026 | Mauch Robert P. CEO | Exercise | Common Stock | $323.9K | +4K +5.75% | 69,155 0.04% of shares | low |
| Mar 5, 2026 | Tyler Lauren M Director | Grant | Common Stock | $200.1K | +557 +17.67% | 3,710 <0.01% of shares | low |
| Mar 5, 2026 | Clyburn Frank Director | Grant | Common Stock | $200.1K | +557 +47.73% | 1,724 <0.01% of shares | low |
| Mar 5, 2026 | Nally Dennis M Director | Grant | Common Stock | $200.1K | +557 +4.49% | 12,959 <0.01% of shares | low |
| Mar 5, 2026 | Kim Lorence H. Director | Grant | Common Stock | $200.1K | +557 +15.81% | 4,081 <0.01% of shares | low |
| Mar 5, 2026 | Cooper Ellen Director | Grant | Common Stock | $200.1K | +557 +397.86% | 697 <0.01% of shares | low |
| Mar 5, 2026 | Ryerkerk Lori Director | Grant | Common Stock | $200.1K | +557 +107.95% | 1,073 <0.01% of shares | low |
| Mar 5, 2026 | Greenberg Lon R Director | Grant | Common Stock | $200.1K | +557 +3.12% | 18,408 <0.01% of shares | low |
| Mar 5, 2026 | Baumann Werner Director | Grant | Common Stock | $200.1K | +557 +17.80% | 3,687 <0.01% of shares | low |
| Mar 5, 2026 | Miller Redonda Director | Grant | Common Stock | $200.1K | +557 +17.44% | 3,751 <0.01% of shares | low |
| Jun 22, 2026 | Tyler Lauren M Director | Buy | Common Stock | $148.6K | +550 +14.44% | 4,359 <0.01% of shares | medium |
| May 1, 2026 | Nally Dennis M Director | Grant | Common Stock | $35.3K | +116 +0.90% | 13,075 <0.01% of shares | low |
| Jan 30, 2026 | Nally Dennis M Director | Grant | Common Stock | $35.2K | +98 +0.80% | 12,402 <0.01% of shares | low |
| Jan 30, 2026 | Tyler Lauren M Director | Grant | Common Stock | $30.2K | +84 +2.74% | 3,153 <0.01% of shares | low |
| May 1, 2026 | Tyler Lauren M Director | Grant | Common Stock | $30.1K | +99 +2.67% | 3,809 <0.01% of shares | low |
| May 1, 2026 | Cooper Ellen Director | Grant | Common Stock | $30.1K | +99 +14.20% | 796 <0.01% of shares | low |
| Jan 30, 2026 | Cooper Ellen Director | Grant | Common Stock | $24.8K | +69 +1380.00% | 74 <0.01% of shares | low |
| Jan 30, 2026 | Cooper Ellen Director | Grant | Common Stock | $23.7K | +66 +89.19% | 140 <0.01% of shares | low |
| Dec 31, 2025 | Campbell Elizabeth S Executive | Grant | Common Stock | $9.6K | +34 +0.14% | 23,925 0.01% of shares | low |
| Dec 31, 2025 | Battaglia Silvana Executive | Grant | Common Stock | $7.9K | +27 +0.15% | 18,824 <0.01% of shares | low |
| Mar 11, 2026 | Battaglia Silvana Executive | Exercise | Common Stock | $0 | +8K +44.70% | 27,239 0.01% of shares | low |
| Mar 11, 2026 | Cleary James F Executive | Exercise | Common Stock | $0 | +13K +8.24% | 165,766 0.09% of shares | low |
| Mar 11, 2026 | Campbell Elizabeth S Executive | Exercise | Common Stock | $0 | +13K +52.76% | 36,548 0.02% of shares | low |
| Jun 29, 2026 | Boratto Eva C Executive | Grant | Restricted Stock Units | — | +21K | 21,304 0.01% of shares | low |
| Apr 1, 2026 | Krikorian Lazarus Executive | Grant | Restricted Stock Units | — | +4K | 3,936 <0.01% of shares | low |
| Mar 11, 2026 | Battaglia Silvana Executive | Exercise | Restricted Stock Units | — | -8K -100.00% | 0 0.00% of shares | low |
| Feb 20, 2026 | Mauch Robert P. CEO | Exercise | Non-qualified Stock Option (Right to Buy) | — | -4K -100.00% | 0 0.00% of shares | low |
| Jan 20, 2026 | Mauch Robert P. CEO | Exercise | Non-qualified Stock Option (Right to Buy) | — | -4K -50.01% | 3,762 <0.01% of shares | low |
| Mar 11, 2026 | Cleary James F Executive | Exercise | Restricted Stock Units | — | -13K -100.00% | 0 0.00% of shares | low |
| Mar 11, 2026 | Campbell Elizabeth S Executive | Exercise | Restricted Stock Units | — | -13K -100.00% | 0 0.00% of shares | low |